PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study

Carrie Thompson, Marek Trněný, Franck Morschhauser, Gilles Salles, Patrick M. Reagan, Mark Hertzberg, Huilai Zhang, Catherine Thieblemont, Bei Hu, Gustavo Fonseca, Won Seog Kim, Maurizio Martelli, Amitkumar Mehta, Avrita Singh, Mark Yan, Jamie Hirata, Matthew Sugidono, Calvin Lee, Jeff P. Sharman, Neha Mehta-Shah, Christopher R. Flowers, Hervé Tilly, Neil Chua, René-Olivier Casasnovas, Fiona Miall, Tae Min Kim, Xavier Cheng-Hong Tsai, Sunita Nasta, Seung Tae Lee, Jonathan W. Friedberg

Open source

DOI: 10.1182/blood.2025028848
Published: 2026-01-15
Container: Blood
Publisher: American Society of Hematology
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/blood.2025028848,
  title = {PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study},
  author = {Carrie Thompson and Marek Trněný and Franck Morschhauser and Gilles Salles and Patrick M. Reagan and Mark Hertzberg and Huilai Zhang and Catherine Thieblemont and Bei Hu and Gustavo Fonseca and Won Seog Kim and Maurizio Martelli and Amitkumar Mehta and Avrita Singh and Mark Yan and Jamie Hirata and Matthew Sugidono and Calvin Lee and Jeff P. Sharman and Neha Mehta-Shah and Christopher R. Flowers and Hervé Tilly and Neil Chua and René-Olivier Casasnovas and Fiona Miall and Tae Min Kim and Xavier Cheng-Hong Tsai and Sunita Nasta and Seung Tae Lee and Jonathan W. Friedberg},
  year = {2026},
  journal = {Blood},
  doi = {10.1182/blood.2025028848},
  url = {https://doi.org/10.1182/blood.2025028848}
}

RIS

TY  - JOUR
TI  - PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study
AU  - Carrie Thompson
AU  - Marek Trněný
AU  - Franck Morschhauser
AU  - Gilles Salles
AU  - Patrick M. Reagan
AU  - Mark Hertzberg
AU  - Huilai Zhang
AU  - Catherine Thieblemont
AU  - Bei Hu
AU  - Gustavo Fonseca
AU  - Won Seog Kim
AU  - Maurizio Martelli
AU  - Amitkumar Mehta
AU  - Avrita Singh
AU  - Mark Yan
AU  - Jamie Hirata
AU  - Matthew Sugidono
AU  - Calvin Lee
AU  - Jeff P. Sharman
AU  - Neha Mehta-Shah
AU  - Christopher R. Flowers
AU  - Hervé Tilly
AU  - Neil Chua
AU  - René-Olivier Casasnovas
AU  - Fiona Miall
AU  - Tae Min Kim
AU  - Xavier Cheng-Hong Tsai
AU  - Sunita Nasta
AU  - Seung Tae Lee
AU  - Jonathan W. Friedberg
PY  - 2026
JO  - Blood
DO  - 10.1182/blood.2025028848
UR  - https://doi.org/10.1182/blood.2025028848
ER  -

APA

Thompson, C., Trněný, M., Morschhauser, F., Salles, G., Reagan, P. M., Hertzberg, M., Zhang, H., Thieblemont, C., Hu, B., Fonseca, G., Kim, W. S., Martelli, M., Mehta, A., Singh, A., Yan, M., Hirata, J., Sugidono, M., Lee, C., Sharman, J. P., Mehta-Shah, N., Flowers, C. R., Tilly, H., Chua, N., Casasnovas, R., Miall, F., Kim, T. M., Tsai, X. C., Nasta, S., Lee, S. T., & Friedberg, J. W. (2026). PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study. Blood. https://doi.org/10.1182/blood.2025028848

Source records

crossref · retrieved 2026-09-26T09:43:17.693Z